All news (page 10)

• 

  28 July 2026

  INEOS Project ONE: final cracker modules reach Antwerp after Strait of Hormuz delay

  First of two final heavy modules reached Antwerp after months trapped in the Strait of Hormuz; second expected shortly as installation and commissioning enter peak phase.
• 

  28 July 2026

  GSK to open flagship R&D centre on Cambridge Biomedical Campus

  New 300,000 sq ft centre will house 1,000+ scientists, focusing on oncology, respiratory, hepatology, vaccines and HIV; £400m UK investment and Stevenage move by 2029.
• 

  28 July 2026

  GSK Q2: strong core results, R&D acceleration and 20+ Phase III starts in 2026

  Core operating profit +7% and core EPS +9%; sales up, driven by Specialty Medicines and Vaccines; new R&D centre and a 3-year £1.9bn annual savings target to fund late-stage pipeline.
• 

  28 July 2026

  Hansoh Pharma/GSK: Ris‑Rez meets PFS endpoint in China phase III ARTEMIS‑011 (relapsed osteosarcoma)

  ARTEMIS‑011 showed significant PFS benefit versus chemotherapy in relapsed osteosarcoma after ≥2 prior therapies; OS benefit and expected safety observed; data to support Chinese submission.
• 

  28 July 2026

  Eni FID for Cronos gas development off Cyprus

  Final Investment Decision for Cronos targets first Cypriot gas in 2028; field holds >3 Tcf GIIP and will route gas via Egypt’s Zohr and Damietta for LNG exports.
• 

  28 July 2026

  Volkswagen fits ID. Buzz spoilers with PLEXIGLAS® (Röhm) Piano Black mold‑in‑color PMMA

  Mold‑in‑color PMMA removes coating, cutting VOCs, energy and water use; delivers Class A glossy, UV‑ and chemical‑resistant exterior parts produced with 2C injection‑compression.

• 

  28 July 2026

  Croda H1 2026 results: £880.5m sales and margin progress from transformation

  Group organic sales +4.6% in H1; adjusted operating profit £155.8m; free cash flow up 36.8%; FY26 guidance unchanged with 3–6% organic range.
• 

  28 July 2026

  Air Liquide H1 2026: near €14bn revenue with Q2 acceleration

  Second-quarter comparable growth accelerated; operating margin, recurring profit and cash flow improved while record investments and the DIG Airgas deal closed.
• 

  28 July 2026

  TotalEnergies approves development of Cronos gas field in Cyprus

  Cyprus' first gas field will send about 2.8 Mtpa LNG to Europe via Egypt's Damietta terminal; start-up expected 2028 and half the output will be marketed to Europe.
• 

  28 July 2026

  Mitsui Chemicals joins CuspAI-led AI Materials Foundry as founding member

  Founding-member move ties chemical R&D to a 45+ partner network using CuspAI’s MIRA platform for end-to-end generative‑AI materials discovery.
• 

  28 July 2026

  AGC Biologics secures long-term manufacturing partnership with leading global biopharma

  Deal covers commercial manufacturing of multiple biopharmaceuticals using new Yokohama site; revenue expected at several tens of billions of yen; GMP services targeted for 2027.
• 

  27 July 2026

  DHL Express secures 6,000 t SAF from Moeve for Madrid gateway

  One-year supply from July 2026–June 2027 covers ~50% of Madrid gateway fuel; SAF from waste/residue feedstocks with ~80% lifecycle GHG savings.
• 

  27 July 2026

  Saipem H1 2026 results

  H1 revenue and margins improved; adjusted EBITDA €836m; strong order intake; guidance adjusted for extra Middle East costs while cash generation remains robust.
• 

  27 July 2026

  Ercros secures €20M ICF loan to decarbonise Tarragona Industrial Complex

  Public EcoVerda financing will fund electric boiler, biomass steam, waste-heat recovery and hydrogen optimisation to cut the complex's CO₂ emissions by 56%.
• 

  27 July 2026

  Technip Energies and EDF sign framework to support EPR2 delivery

  Agreement embeds external project and construction management personnel into nuclear new-build teams to boost execution discipline and schedule predictability.
• 

  27 July 2026

  Galp 2Q26 results and guidance update

  Strong cash generation and higher earnings supported a proposed 10% dividend rise to €0.70/share; Bacalhau ramp-up and a €318m renewables purchase shaped the quarter.
• 

  27 July 2026

  Saipem awarded ~€800m Eni contracts for Ivory Coast offshore and Venice biorefinery

  Two awards cover Baleine Phase 3 offshore pipelines and subsea systems, and an EPC deoxygenation unit at the Venice biorefinery to boost HVO output.
• 

  27 July 2026

  argenx to acquire Forte Biosciences, adding anti‑CD122 candidate FB102

  FB102 shows Phase 1b proof in vitiligo and celiac; Phase 2 in celiac expected H2 2026. Acquisition executed as $77/share cash tender offer; close targeted Q3 2026.
• 

  27 July 2026

  Shengli Jiyang completes China's first continental rift lake basin shale‑oil demonstration area

  New three‑dimensional development model delivered two 100Mt fields, added 327Mt proven reserves, cut 6,000m well drilling to 17 days, raised single‑well output and reduced energy use.
• 

  26 July 2026

  BASF starts global registration for Replexor Active (fendioxypyracil)

  Novel PPO herbicide targets broadleaf weeds and key annual grasses; dossiers filed in Brazil and Australia with US and Argentina filings planned next year and market entry aimed ~2030.
• 

  24 July 2026

  Roche’s Susvimo recommended by CHMP for nAMD

  First continuous‑delivery ranibizumab implant for nAMD receives CHMP backing; designed to maintain vision with as few as two refills per year versus monthly injections.
• 

  24 July 2026

  Atyrau Refinery completes preventive maintenance and returns to operation

  Refinery resumed operations after PM; now processing 16.2 Kt/d and has shipped gasoline, diesel and LPG while major inspections, catalyst renewals and VDU work were completed.
• 

  24 July 2026

  Petrobras P-33 heads from Açu Port to Rio Grande for sustainable recycling

  Platform sold to Gerdau and Grupo Ecovix will be recycled at Rio Grande under a sustainable dismantling plan; it left Açu Port after being docked since Feb 2024.
• 

  24 July 2026

  MOL Group launches court challenge to Hungary CO2 quota tax

  Seeks refund after Tax Authority rejection; challenges follow EU court ruling that the tax breaches directives. Dispute valued at HUF 126.0 billion (~USD 395m).
• 

  24 July 2026

  Merck outlines LMIC access plans for alimatravir with 129‑country voluntary licenses

  Early, multi-faceted plan includes seven royalty‑free licenses covering 129 LMICs, regional manufacturing support in Africa and Latin America, and early manufacturing investment to speed availability.
• 

  24 July 2026

  Catalyxx to build €120M renewable chemicals plant at ZILS, Sines

  First commercial facility will convert bioethanol into butanol, hexanol and octanol, offering low‑carbon alternatives to petrochemical products.
• 

  24 July 2026

  Neste names Elim Yeoh President, Renewable Products North America

  Seasoned biofuels executive to lead North American renewable products business, commercial operations and feedstock sourcing; will represent the company on the Martinez JV board.
• 

  24 July 2026

  Neste Q2 2026: record renewable margins lift EBITDA

  Record quarterly EBITDA driven by USD 1,223/t renewable sales margin and strong middle‑distillate refining cracks; H2 includes three planned turnarounds and ~€1.2bn capex.
• 

  24 July 2026

  AGC to transfer its APK shares to Saint‑Gobain K.K.

  Transfer covers a 50.72% holding in APK, a producer of polyurethane waterproofing and flooring materials; closing expected around Dec 2026 pending approvals.
• 

  24 July 2026

  Infineum and Kangtai expand partnership with Southern Asia distribution deal

  Distribution arrangement lets Southern Asia distributors add partner’s additives and components, broadening product lines and supporting Kangtai’s regional expansion.